Evidence map›Paper›PMID 27752777›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2016

Effects of intravitreally injected Fc fragment on rat eyes.

Tatjana Taubitz, Laura-Pia Steinbrenner, Alexander V Tschulakow, Antje Biesemeier, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tatjana TaubitzCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany.
Laura-Pia SteinbrennerCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany.
Alexander V TschulakowCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany.
Antje BiesemeierCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany. antje.biesemeier@med.uni-tuebingen.de.
Sylvie Julien-SchraermeyerCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany.
Ulrich SchraermeyerCentre for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Schleichstrasse 12/1, Tuebingen, Germany.
STZ eyetrial · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAnti-vascular endothelial growth factor (VEGF) drugs are used to treat neovascular eye diseases. Some of these drugs contain Fc fragments (Fc), but it is unknown how their mode of action is influenced by Fc. Therefore, this study investigated the effects of Fc on rat eyes after intravitreal injection.

methodsEighteen Long-Evans rats were intravitreally injected with sterile, biotin-labeled rat Fc (9.1 μg in 5 μl PBS). For control, 5 μl PBS was injected in another nine rats. Animals were sacrificed between 1 and 3 days (group 1), 7 days (group 2), and 14 days (group 3) after injection. The right eyes were examined by electron microscopy (EM). The left eyes were stained by immunohistochemistry to investigate the distribution of Fc and the presence of macrophages.

resultsAfter 1 day, Fc had penetrated into the anterior chamber and the retina up to the inner nuclear layer, and was located especially in retinal vessels. High numbers of infiltrating cells were present within the vitreous, around the ciliary body, anterior chamber and inside the retina 1-3 days after Fc injection (p < 0.02 group 1 vs. control). Immunohistochemistry and EM showed that they were macrophages or granulocytes in close association with Fc. Ultrastructurally, there were effects on the blood vessels such as thrombocyte activation and fibrin formation.

conclusionsBiotin labeling is ideal for investigating the distribution of intravitreally injected proteins in ocular tissue. Fc fragments at a dose corresponding to their concentration in standard AMD treatments induced inflammation, and particularly the attraction of immune-competent cells. This may be associated with the risk of inflammation or endophthalmitis after anti-VEGF treatment, and needs further investigation.

Indexed as

AnimalsDisease Models, AnimalEndophthalmitisImmunoglobulin Fc FragmentsImmunohistochemistryImmunologic FactorsIntravitreal InjectionsMicroscopy, ElectronRatsRats, Long-EvansRetinaVascular Endothelial Growth Factor AVitreous BodyImmunoglobulin Fc FragmentsImmunologic FactorsVascular Endothelial Growth Factor AAnti-VEGF therapyEndophthalmitisFc fragmentIntravitreal injection

Identifiers

PMID27752777
OpenAlexW2534412346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.